[LGND] QoQ Quarter Result on 30-Sep-2012 [#Q3]

Stock
[LGND] Ligand Pharmaceuticals Incorporated
Announcement Date
14-Nov-2012
Financial Year
2012
Quarter
30-Sep-2012 [#Q3]
Profit Trend
QoQ- 91.44%
YoY- 95.03%
Quarter Report
LGND's Result
LGND's Financial Summary
View:
Show?
Quarter Result
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
Revenue 9,580 11,651 13,635 6,375 5,742 5,636 12,936 -18.16%
PBT 3,804 1,370 950 -52 -3,728 -522 5,997 -26.19%
Tax 110 66 -1,636 142 338 -35 495 -63.34%
NP 6,091 1,495 1,063 -194 -2,267 1,133 5,502 7.02%
Tax Rate -2.89% -4.82% 172.21% - - - -8.25% -
Total Cost 3,489 10,156 12,572 6,569 8,009 4,503 7,434 -39.63%
Ratio Analysis
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
NP Margin 63.58 12.83 7.80 -3.04 -39.48 20.10 42.53 30.77%
Per Share
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
EPS 0.30 0.07 0.05 -0.01 -0.11 0.07 0.28 4.71%
EPS Diluted 0.30 0.07 0.05 -0.01 -0.11 0.07 0.28 4.71%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.